108 related articles for article (PubMed ID: 15225616)
21. SDF-1 and CXCR4 in synovium are associated with disease activity and bone and joint destruction in patients with rheumatoid arthritis treated with golimumab.
Kanbe K; Chiba J; Inoue Y; Taguchi M; Yabuki A
Mod Rheumatol; 2016; 26(1):46-50. PubMed ID: 25995033
[TBL] [Abstract][Full Text] [Related]
22. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
[TBL] [Abstract][Full Text] [Related]
23. Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells.
Burger M; Glodek A; Hartmann T; Schmitt-Gräff A; Silberstein LE; Fujii N; Kipps TJ; Burger JA
Oncogene; 2003 Nov; 22(50):8093-101. PubMed ID: 14603250
[TBL] [Abstract][Full Text] [Related]
24. Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression.
Perissinotto E; Cavalloni G; Leone F; Fonsato V; Mitola S; Grignani G; Surrenti N; Sangiolo D; Bussolino F; Piacibello W; Aglietta M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):490-7. PubMed ID: 15701832
[TBL] [Abstract][Full Text] [Related]
25. Rapid and recurrent neutrophil mobilization regulated by T134, a CXCR4 peptide antagonist.
Iyer CV; Evans RJ; Lou Q; Lin D; Wang J; Kohn W; Yan LZ; Pulley S; Peng SB
Exp Hematol; 2008 Sep; 36(9):1098-109. PubMed ID: 18495324
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of potent CXCR4 inhibitors possessing low cytotoxicity and improved biostability based on T140 derivatives.
Tamamura H; Hiramatsu K; Kusano aS; Terakubo S; Yamamoto N; Trent JO; Wang Z; Peiper SC; Nakashima H; Otaka A; Fujii N
Org Biomol Chem; 2003 Nov; 1(21):3656-62. PubMed ID: 14649896
[TBL] [Abstract][Full Text] [Related]
27. Exploratory studies on development of the chemokine receptor CXCR4 antagonists toward downsizing.
Tamamura H; Tsutsumi H; Nomura W; Fujii N
Perspect Medicin Chem; 2008 Feb; 2():1-9. PubMed ID: 19787093
[TBL] [Abstract][Full Text] [Related]
28. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model.
Kitaori T; Ito H; Schwarz EM; Tsutsumi R; Yoshitomi H; Oishi S; Nakano M; Fujii N; Nagasawa T; Nakamura T
Arthritis Rheum; 2009 Mar; 60(3):813-23. PubMed ID: 19248097
[TBL] [Abstract][Full Text] [Related]
29. Enhanced unique pattern of hematopoietic cell mobilization induced by the CXCR4 antagonist 4F-benzoyl-TN14003.
Abraham M; Biyder K; Begin M; Wald H; Weiss ID; Galun E; Nagler A; Peled A
Stem Cells; 2007 Sep; 25(9):2158-66. PubMed ID: 17525235
[TBL] [Abstract][Full Text] [Related]
30. A single treatment with microcapsules containing a CXCR4 antagonist suppresses pulmonary metastasis of murine melanoma.
Takenaga M; Tamamura H; Hiramatsu K; Nakamura N; Yamaguchi Y; Kitagawa A; Kawai S; Nakashima H; Fujii N; Igarashi R
Biochem Biophys Res Commun; 2004 Jul; 320(1):226-32. PubMed ID: 15207725
[TBL] [Abstract][Full Text] [Related]
31. Pharmacophore identification of a specific CXCR4 inhibitor, T140, leads to development of effective anti-HIV agents with very high selectivity indexes.
Tamamura H; Omagari A; Oishi S; Kanamoto T; Yamamoto N; Peiper SC; Nakashima H; Otaka A; Fujii N
Bioorg Med Chem Lett; 2000 Dec; 10(23):2633-7. PubMed ID: 11128640
[TBL] [Abstract][Full Text] [Related]
32. Tannic acid is an inhibitor of CXCL12 (SDF-1alpha)/CXCR4 with antiangiogenic activity.
Chen X; Beutler JA; McCloud TG; Loehfelm A; Yang L; Dong HF; Chertov OY; Salcedo R; Oppenheim JJ; Howard OM
Clin Cancer Res; 2003 Aug; 9(8):3115-23. PubMed ID: 12912963
[TBL] [Abstract][Full Text] [Related]
33. Hyperoside exerts anti-inflammatory and anti-arthritic effects in LPS-stimulated human fibroblast-like synoviocytes in vitro and in mice with collagen-induced arthritis.
Jin XN; Yan EZ; Wang HM; Sui HJ; Liu Z; Gao W; Jin Y
Acta Pharmacol Sin; 2016 May; 37(5):674-86. PubMed ID: 27041460
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus.
Henneken M; Dörner T; Burmester GR; Berek C
Arthritis Res Ther; 2005; 7(5):R1001-13. PubMed ID: 16207316
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non-small cell lung cancer.
Fahham D; Weiss ID; Abraham M; Beider K; Hanna W; Shlomai Z; Eizenberg O; Zamir G; Izhar U; Shapira OM; Peled A; Wald O
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1167-1175.e1. PubMed ID: 22925564
[TBL] [Abstract][Full Text] [Related]
36. Induction of myogenic differentiation by SDF-1 via CXCR4 and CXCR7 receptors.
Melchionna R; Di Carlo A; De Mori R; Cappuzzello C; Barberi L; Musarò A; Cencioni C; Fujii N; Tamamura H; Crescenzi M; Capogrossi MC; Napolitano M; Germani A
Muscle Nerve; 2010 Jun; 41(6):828-35. PubMed ID: 20151462
[TBL] [Abstract][Full Text] [Related]
37. CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells.
Kabashima K; Shiraishi N; Sugita K; Mori T; Onoue A; Kobayashi M; Sakabe J; Yoshiki R; Tamamura H; Fujii N; Inaba K; Tokura Y
Am J Pathol; 2007 Oct; 171(4):1249-57. PubMed ID: 17823289
[TBL] [Abstract][Full Text] [Related]
38. Tissue trafficking patterns of effector memory CD4+ T cells in rheumatoid arthritis.
Zhang X; Nakajima T; Goronzy JJ; Weyand CM
Arthritis Rheum; 2005 Dec; 52(12):3839-49. PubMed ID: 16329093
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist.
Princen K; Hatse S; Vermeire K; Aquaro S; De Clercq E; Gerlach LO; Rosenkilde M; Schwartz TW; Skerlj R; Bridger G; Schols D
J Virol; 2004 Dec; 78(23):12996-3006. PubMed ID: 15542651
[TBL] [Abstract][Full Text] [Related]
40. TCR activation inhibits chemotaxis toward stromal cell-derived factor-1: evidence for reciprocal regulation between CXCR4 and the TCR.
Peacock JW; Jirik FR
J Immunol; 1999 Jan; 162(1):215-23. PubMed ID: 9886389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
